Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study
Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups. We prospectively randomized 114 patients...
Gespeichert in:
Veröffentlicht in: | Circulation. Arrhythmia and electrophysiology 2020-09, Vol.13 (9), p.e008531-e008531 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e008531 |
---|---|
container_issue | 9 |
container_start_page | e008531 |
container_title | Circulation. Arrhythmia and electrophysiology |
container_volume | 13 |
creator | Pak, Hui-Nam Park, Junbeom Park, Je-Wook Yang, Song-Yi Yu, Hee Tae Kim, Tae-Hoon Uhm, Jae-Sun Choi, Jong-Il Joung, Boyoung Lee, Moon-Hyoung Kim, Young-Hoon Shim, Jaemin |
description | Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups.
We prospectively randomized 114 patients with persistent AF to paroxysmal AF (men, 75%; 59.8±9.9 years old) to circumferential pulmonary vein isolation (CPVI) alone group (n=57) and additional POBI group (n=57). Primary end point was AF recurrence after a single procedure, and secondary end points were recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs.
After a mean follow-up of 23.8±10.2 months, the clinical recurrence rate did not significantly differ between the CPVI alone and additional POBI group (31.6% versus 28.1%;
=0.682; log-rank
=0.729). The recurrences as atrial tachycardias (5.3% versus 12.3%;
=0.134) and cardioversion rates (5.3% versus 10.5%;
=0.250) were not significantly different between the CPVI and POBI groups. At the final follow-up, sinus rhythm was maintained without antiarrhythmic drug in 52.6% of CPVI group and 59.6% of POBI group (
=0.450). No significant difference was found in major complication rates between the two groups (5.3% versus 1.8%;
=0.618), but the total ablation time was significantly longer in the POBI group (4187±952 versus 5337±1517 s; |
doi_str_mv | 10.1161/CIRCEP.120.008531 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2430978763</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2430978763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3465-38537b2b89afd42bcb80eace61e251175dfe5335ad8e06e608d930deae1263403</originalsourceid><addsrcrecordid>eNptkUGP1CAYhonRuOvqD_BiOHrYjh_Q0tbb2MzqJGtsVj0TWr5x0LbMAnV3_C3-WDEdjQcPBBKe780LDyHPGawYk-xVs71pNu2KcVgBVIVgD8g5q3OWCajyh_-cz8iTEL4CSFYx-ZicCV4WhajlOfm5GbCP3vZ6oK0LEb11nr5x93Qb3KCjdRO1E23RB5tup0jXiU7wle28HU5Es9fTFzQ0Otpq7-6PYUzIf8jXdE3fz0O0fYpCf0lb78IhNbDf8ZLe6Mm40f5ISR_jbI5PyaOdHgI-O-0X5PPV5lPzLrv-8HbbrK-zXuSyyER6etnxrqr1zuS867sKUPcoGfKCsbIwOyyEKLSpECRKqEwtwKBGxqXIQVyQl0vuwbvbGUNUow09ps4Tujkonguoy6qUIqFsQftUPHjcqYO3o_ZHxUD9lqIWKSpJUYuUNPPiFD93I5q_E38sJCBfgDs3pF8J34b5Dr3aox7iXgETosxrkXHgADUAZGlBIX4BbDeabA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2430978763</pqid></control><display><type>article</type><title>Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Pak, Hui-Nam ; Park, Junbeom ; Park, Je-Wook ; Yang, Song-Yi ; Yu, Hee Tae ; Kim, Tae-Hoon ; Uhm, Jae-Sun ; Choi, Jong-Il ; Joung, Boyoung ; Lee, Moon-Hyoung ; Kim, Young-Hoon ; Shim, Jaemin</creator><creatorcontrib>Pak, Hui-Nam ; Park, Junbeom ; Park, Je-Wook ; Yang, Song-Yi ; Yu, Hee Tae ; Kim, Tae-Hoon ; Uhm, Jae-Sun ; Choi, Jong-Il ; Joung, Boyoung ; Lee, Moon-Hyoung ; Kim, Young-Hoon ; Shim, Jaemin</creatorcontrib><description>Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups.
We prospectively randomized 114 patients with persistent AF to paroxysmal AF (men, 75%; 59.8±9.9 years old) to circumferential pulmonary vein isolation (CPVI) alone group (n=57) and additional POBI group (n=57). Primary end point was AF recurrence after a single procedure, and secondary end points were recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs.
After a mean follow-up of 23.8±10.2 months, the clinical recurrence rate did not significantly differ between the CPVI alone and additional POBI group (31.6% versus 28.1%;
=0.682; log-rank
=0.729). The recurrences as atrial tachycardias (5.3% versus 12.3%;
=0.134) and cardioversion rates (5.3% versus 10.5%;
=0.250) were not significantly different between the CPVI and POBI groups. At the final follow-up, sinus rhythm was maintained without antiarrhythmic drug in 52.6% of CPVI group and 59.6% of POBI group (
=0.450). No significant difference was found in major complication rates between the two groups (5.3% versus 1.8%;
=0.618), but the total ablation time was significantly longer in the POBI group (4187±952 versus 5337±1517 s;
<0.001).
In patients with persistent AF converted to paroxysmal AF by antiarrhythmic drug, the addition of POBI to CPVI did not improve the rhythm outcome of catheter ablation or influence overall safety, while leading to longer ablation time. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02176616.</description><identifier>ISSN: 1941-3084</identifier><identifier>ISSN: 1941-3149</identifier><identifier>EISSN: 1941-3084</identifier><identifier>DOI: 10.1161/CIRCEP.120.008531</identifier><identifier>PMID: 32755396</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Action Potentials ; Aged ; Anti-Arrhythmia Agents - therapeutic use ; Atrial Fibrillation - diagnosis ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - surgery ; Catheter Ablation - adverse effects ; Female ; Heart Rate - drug effects ; Humans ; Male ; Middle Aged ; Operative Time ; Prospective Studies ; Pulmonary Veins - drug effects ; Pulmonary Veins - physiopathology ; Pulmonary Veins - surgery ; Recurrence ; Risk Factors ; Seoul ; Time Factors ; Treatment Outcome</subject><ispartof>Circulation. Arrhythmia and electrophysiology, 2020-09, Vol.13 (9), p.e008531-e008531</ispartof><rights>American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3465-38537b2b89afd42bcb80eace61e251175dfe5335ad8e06e608d930deae1263403</citedby><cites>FETCH-LOGICAL-c3465-38537b2b89afd42bcb80eace61e251175dfe5335ad8e06e608d930deae1263403</cites><orcidid>0000-0002-3256-3620 ; 0000-0002-1611-8172 ; 0000-0002-0261-161X ; 0000-0003-4200-3456 ; 0000-0001-6617-508X ; 0000-0001-9036-7225 ; 0000-0001-8251-1522 ; 0000-0002-4254-647X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32755396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pak, Hui-Nam</creatorcontrib><creatorcontrib>Park, Junbeom</creatorcontrib><creatorcontrib>Park, Je-Wook</creatorcontrib><creatorcontrib>Yang, Song-Yi</creatorcontrib><creatorcontrib>Yu, Hee Tae</creatorcontrib><creatorcontrib>Kim, Tae-Hoon</creatorcontrib><creatorcontrib>Uhm, Jae-Sun</creatorcontrib><creatorcontrib>Choi, Jong-Il</creatorcontrib><creatorcontrib>Joung, Boyoung</creatorcontrib><creatorcontrib>Lee, Moon-Hyoung</creatorcontrib><creatorcontrib>Kim, Young-Hoon</creatorcontrib><creatorcontrib>Shim, Jaemin</creatorcontrib><title>Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study</title><title>Circulation. Arrhythmia and electrophysiology</title><addtitle>Circ Arrhythm Electrophysiol</addtitle><description>Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups.
We prospectively randomized 114 patients with persistent AF to paroxysmal AF (men, 75%; 59.8±9.9 years old) to circumferential pulmonary vein isolation (CPVI) alone group (n=57) and additional POBI group (n=57). Primary end point was AF recurrence after a single procedure, and secondary end points were recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs.
After a mean follow-up of 23.8±10.2 months, the clinical recurrence rate did not significantly differ between the CPVI alone and additional POBI group (31.6% versus 28.1%;
=0.682; log-rank
=0.729). The recurrences as atrial tachycardias (5.3% versus 12.3%;
=0.134) and cardioversion rates (5.3% versus 10.5%;
=0.250) were not significantly different between the CPVI and POBI groups. At the final follow-up, sinus rhythm was maintained without antiarrhythmic drug in 52.6% of CPVI group and 59.6% of POBI group (
=0.450). No significant difference was found in major complication rates between the two groups (5.3% versus 1.8%;
=0.618), but the total ablation time was significantly longer in the POBI group (4187±952 versus 5337±1517 s;
<0.001).
In patients with persistent AF converted to paroxysmal AF by antiarrhythmic drug, the addition of POBI to CPVI did not improve the rhythm outcome of catheter ablation or influence overall safety, while leading to longer ablation time. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02176616.</description><subject>Action Potentials</subject><subject>Aged</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Atrial Fibrillation - diagnosis</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - surgery</subject><subject>Catheter Ablation - adverse effects</subject><subject>Female</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Operative Time</subject><subject>Prospective Studies</subject><subject>Pulmonary Veins - drug effects</subject><subject>Pulmonary Veins - physiopathology</subject><subject>Pulmonary Veins - surgery</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>Seoul</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1941-3084</issn><issn>1941-3149</issn><issn>1941-3084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkUGP1CAYhonRuOvqD_BiOHrYjh_Q0tbb2MzqJGtsVj0TWr5x0LbMAnV3_C3-WDEdjQcPBBKe780LDyHPGawYk-xVs71pNu2KcVgBVIVgD8g5q3OWCajyh_-cz8iTEL4CSFYx-ZicCV4WhajlOfm5GbCP3vZ6oK0LEb11nr5x93Qb3KCjdRO1E23RB5tup0jXiU7wle28HU5Es9fTFzQ0Otpq7-6PYUzIf8jXdE3fz0O0fYpCf0lb78IhNbDf8ZLe6Mm40f5ISR_jbI5PyaOdHgI-O-0X5PPV5lPzLrv-8HbbrK-zXuSyyER6etnxrqr1zuS867sKUPcoGfKCsbIwOyyEKLSpECRKqEwtwKBGxqXIQVyQl0vuwbvbGUNUow09ps4Tujkonguoy6qUIqFsQftUPHjcqYO3o_ZHxUD9lqIWKSpJUYuUNPPiFD93I5q_E38sJCBfgDs3pF8J34b5Dr3aox7iXgETosxrkXHgADUAZGlBIX4BbDeabA</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Pak, Hui-Nam</creator><creator>Park, Junbeom</creator><creator>Park, Je-Wook</creator><creator>Yang, Song-Yi</creator><creator>Yu, Hee Tae</creator><creator>Kim, Tae-Hoon</creator><creator>Uhm, Jae-Sun</creator><creator>Choi, Jong-Il</creator><creator>Joung, Boyoung</creator><creator>Lee, Moon-Hyoung</creator><creator>Kim, Young-Hoon</creator><creator>Shim, Jaemin</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3256-3620</orcidid><orcidid>https://orcid.org/0000-0002-1611-8172</orcidid><orcidid>https://orcid.org/0000-0002-0261-161X</orcidid><orcidid>https://orcid.org/0000-0003-4200-3456</orcidid><orcidid>https://orcid.org/0000-0001-6617-508X</orcidid><orcidid>https://orcid.org/0000-0001-9036-7225</orcidid><orcidid>https://orcid.org/0000-0001-8251-1522</orcidid><orcidid>https://orcid.org/0000-0002-4254-647X</orcidid></search><sort><creationdate>20200901</creationdate><title>Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study</title><author>Pak, Hui-Nam ; Park, Junbeom ; Park, Je-Wook ; Yang, Song-Yi ; Yu, Hee Tae ; Kim, Tae-Hoon ; Uhm, Jae-Sun ; Choi, Jong-Il ; Joung, Boyoung ; Lee, Moon-Hyoung ; Kim, Young-Hoon ; Shim, Jaemin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3465-38537b2b89afd42bcb80eace61e251175dfe5335ad8e06e608d930deae1263403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Action Potentials</topic><topic>Aged</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Atrial Fibrillation - diagnosis</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - surgery</topic><topic>Catheter Ablation - adverse effects</topic><topic>Female</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Operative Time</topic><topic>Prospective Studies</topic><topic>Pulmonary Veins - drug effects</topic><topic>Pulmonary Veins - physiopathology</topic><topic>Pulmonary Veins - surgery</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>Seoul</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pak, Hui-Nam</creatorcontrib><creatorcontrib>Park, Junbeom</creatorcontrib><creatorcontrib>Park, Je-Wook</creatorcontrib><creatorcontrib>Yang, Song-Yi</creatorcontrib><creatorcontrib>Yu, Hee Tae</creatorcontrib><creatorcontrib>Kim, Tae-Hoon</creatorcontrib><creatorcontrib>Uhm, Jae-Sun</creatorcontrib><creatorcontrib>Choi, Jong-Il</creatorcontrib><creatorcontrib>Joung, Boyoung</creatorcontrib><creatorcontrib>Lee, Moon-Hyoung</creatorcontrib><creatorcontrib>Kim, Young-Hoon</creatorcontrib><creatorcontrib>Shim, Jaemin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation. Arrhythmia and electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pak, Hui-Nam</au><au>Park, Junbeom</au><au>Park, Je-Wook</au><au>Yang, Song-Yi</au><au>Yu, Hee Tae</au><au>Kim, Tae-Hoon</au><au>Uhm, Jae-Sun</au><au>Choi, Jong-Il</au><au>Joung, Boyoung</au><au>Lee, Moon-Hyoung</au><au>Kim, Young-Hoon</au><au>Shim, Jaemin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study</atitle><jtitle>Circulation. Arrhythmia and electrophysiology</jtitle><addtitle>Circ Arrhythm Electrophysiol</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>13</volume><issue>9</issue><spage>e008531</spage><epage>e008531</epage><pages>e008531-e008531</pages><issn>1941-3084</issn><issn>1941-3149</issn><eissn>1941-3084</eissn><abstract>Persistent atrial fibrillation (AF) can change to paroxysmal AF after antiarrhythmic drug medication and cardioversion. We investigated whether electrical posterior box isolation (POBI) may improve rhythm outcome of catheter ablation in those patient groups.
We prospectively randomized 114 patients with persistent AF to paroxysmal AF (men, 75%; 59.8±9.9 years old) to circumferential pulmonary vein isolation (CPVI) alone group (n=57) and additional POBI group (n=57). Primary end point was AF recurrence after a single procedure, and secondary end points were recurrence pattern, cardioversion rate, and response to antiarrhythmic drugs.
After a mean follow-up of 23.8±10.2 months, the clinical recurrence rate did not significantly differ between the CPVI alone and additional POBI group (31.6% versus 28.1%;
=0.682; log-rank
=0.729). The recurrences as atrial tachycardias (5.3% versus 12.3%;
=0.134) and cardioversion rates (5.3% versus 10.5%;
=0.250) were not significantly different between the CPVI and POBI groups. At the final follow-up, sinus rhythm was maintained without antiarrhythmic drug in 52.6% of CPVI group and 59.6% of POBI group (
=0.450). No significant difference was found in major complication rates between the two groups (5.3% versus 1.8%;
=0.618), but the total ablation time was significantly longer in the POBI group (4187±952 versus 5337±1517 s;
<0.001).
In patients with persistent AF converted to paroxysmal AF by antiarrhythmic drug, the addition of POBI to CPVI did not improve the rhythm outcome of catheter ablation or influence overall safety, while leading to longer ablation time. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02176616.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>32755396</pmid><doi>10.1161/CIRCEP.120.008531</doi><orcidid>https://orcid.org/0000-0002-3256-3620</orcidid><orcidid>https://orcid.org/0000-0002-1611-8172</orcidid><orcidid>https://orcid.org/0000-0002-0261-161X</orcidid><orcidid>https://orcid.org/0000-0003-4200-3456</orcidid><orcidid>https://orcid.org/0000-0001-6617-508X</orcidid><orcidid>https://orcid.org/0000-0001-9036-7225</orcidid><orcidid>https://orcid.org/0000-0001-8251-1522</orcidid><orcidid>https://orcid.org/0000-0002-4254-647X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1941-3084 |
ispartof | Circulation. Arrhythmia and electrophysiology, 2020-09, Vol.13 (9), p.e008531-e008531 |
issn | 1941-3084 1941-3149 1941-3084 |
language | eng |
recordid | cdi_proquest_miscellaneous_2430978763 |
source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Action Potentials Aged Anti-Arrhythmia Agents - therapeutic use Atrial Fibrillation - diagnosis Atrial Fibrillation - physiopathology Atrial Fibrillation - surgery Catheter Ablation - adverse effects Female Heart Rate - drug effects Humans Male Middle Aged Operative Time Prospective Studies Pulmonary Veins - drug effects Pulmonary Veins - physiopathology Pulmonary Veins - surgery Recurrence Risk Factors Seoul Time Factors Treatment Outcome |
title | Electrical Posterior Box Isolation in Persistent Atrial Fibrillation Changed to Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Randomized Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T22%3A38%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Electrical%20Posterior%20Box%20Isolation%20in%20Persistent%20Atrial%20Fibrillation%20Changed%20to%20Paroxysmal%20Atrial%20Fibrillation:%20A%20Multicenter,%20Prospective,%20Randomized%20Study&rft.jtitle=Circulation.%20Arrhythmia%20and%20electrophysiology&rft.au=Pak,%20Hui-Nam&rft.date=2020-09-01&rft.volume=13&rft.issue=9&rft.spage=e008531&rft.epage=e008531&rft.pages=e008531-e008531&rft.issn=1941-3084&rft.eissn=1941-3084&rft_id=info:doi/10.1161/CIRCEP.120.008531&rft_dat=%3Cproquest_cross%3E2430978763%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2430978763&rft_id=info:pmid/32755396&rfr_iscdi=true |